Stay updated on Anti-MAP Therapy in Crohn's: Clinical Trial
Sign up to get notified when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.

Latest updates to the Anti-MAP Therapy in Crohn's: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed significant details regarding a clinical study on RHB-104 for Crohn's Disease, including the study's hypothesis, design, and inclusion/exclusion criteria, while retaining the mention of Crohn's Disease and the drug RHB-104.SummaryDifference17%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to Anti-MAP Therapy in Crohn's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.